Publications by Dr Frida Ponthan - ePrints

Browsing publications by Dr Frida Ponthan.

Newcastle Authors	Title	Year
Dr Alex Elder Dr Simon Bomken Dr Ian Wilson Dr Helen Blair Dr Simon Cockell et al.	Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia	2017
Judith Weiland Dr Deepali Pal Marian Case Professor Julie Irving Dr Frida Ponthan et al.	BCP-ALL blasts are not dependent on CD19 expression for leukaemic maintenance	2016
Dr Frida Ponthan Professor Olaf Heidenreich Dr Kelly Coffey	Gene Silencing by RNAi in Mammalian Cells	2015
Professor Julie Irving Elizabeth Matheson Helen Blair Marian Case Isabella Swidenbank et al.	Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood. 2014;124(23):3420-3430	2015
Dr Frida Ponthan Dr Simon Bomken Dr Deepali Pal Dr Alex Elder Hesta McNeill et al.	A Genome-Wide RNAi Screen to Identify Novel Genes Involved in Clonal Maintenance of ALL	2014
Dr Emma Bell Dr Frida Ponthan Claire Whitworth Professor Deborah Tweddle Professor John Lunec et al.	COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib	2014
Professor Julie Irving Elizabeth Matheson Dr Helen Blair Marian Case Isabella Swidenbank et al.	Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition	2014
Michael Batey Dr Frida Ponthan Dr Helen Blair Professor Olaf Heidenreich	The development and evaluation of a series of novel in vivo imaging models of AML for the assessment of drug efficacy	2014
Dr Frida Ponthan Claire Whitworth Huw Thomas Dr Chris Redfern	Cell Survival Signalling through PPARδ and Arachidonic Acid Metabolites in Neuroblastoma	2013
Dr Simon Bomken Dr Lars Buechler Dr Klaus Rehe Dr Frida Ponthan Dr Alex Elder et al.	Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression	2013
Michael Batey Dr Frida Ponthan Professor Olaf Heidenreich	The use of a novel in vivo orthotopic imaging model of AML for assessment of drug efficacy	2013
Dr Simon Bomken Dr Lars Buechler Dr Klaus Rehe Dr Frida Ponthan Dr Helen Blair et al.	Lentiviral Transduction of Patient Derived Leukaemic Blasts Allowing In Vivo Bioluminescent Monitoring in An NSG Model of Leukaemia Stem Cell Maintenance	2011
Dr Frida Ponthan Hesta McNeill Dr Lars Buechler Professor Hermann Josef Vormoor Professor Olaf Heidenreich et al.	Significance of Fusion Genes for Maintenance of Leukaemia	2011
Dr Frida Ponthan Professor Olaf Heidenreich	A Drosophila model identifies calpains as modulators of the human leukemogenic fusion protein AML1-ETO	2009
Dr Frida Ponthan	Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy	2008
Dr Katrina Wood Dr Michael Jackson Dr Maria Lastowska Dr Darroch Hall Dr Helen Imrie et al.	Histological profile of tumours from MYCN transgenic mice	2008
Dr Frida Ponthan Dr Chris Redfern	Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo	2007
Dr Frida Ponthan	Neuroblastoma cell death in response to docosahexaenoic acid: Sensitization to chemotherapy and arsenic-induced oxidative stress	2006
Dr Frida Ponthan	The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo	2006
Dr Frida Ponthan	NSAIDs in neuroblastoma therapy	2005
Dr Frida Ponthan	Proton magnetic resonance spectroscopy in neuroblastoma: Current status, prospects and limitations	2005
Dr Frida Ponthan	Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo	2004
Dr Frida Ponthan	Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL	2004
Dr Frida Ponthan	Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate	2003
Dr Frida Ponthan	Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts	2003
Dr Frida Ponthan	Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1H MRS)	2003
Dr Frida Ponthan	Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrow	2003
Dr Frida Ponthan	The synthetic retinoid RO 13-6307 induces neuroblastoma differentiation in vitro and inhibits neuroblastoma tumour growth in vivo	2003
Dr Frida Ponthan	Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat	2001
Dr Frida Ponthan Dr Chris Redfern	The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo	2001
Dr Frida Ponthan	Human polyomavirus BK (BKV) and neuroblastoma: Mechanisms of oncogenic action and possible strategy for novel treatment	2000